Biopreservation Market Research Report – Forecast to 2027

Biopreservation Market Research Information: By Product (Media, Equipment), Biospecimen (Human Tissue Sample, Stem Cell), Application (Regenerative Medicine (Gene Therapy, Cell Therapy), Biobanking (Human Egg), Drug Discovery)–Global Forecast Till 2027

ID: MRFR/MED/4946-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The global biopreservation market is expected to grow during the forecast period (2018–2023) at a CAGR ~11.2%.


Biopreservation is a use of natural flora and its antibacterial products to preserve biological material. Biopreservation is playing an important role in healthcare and food industry to preserve the biological material or food product for a long time. The increasing expenditure on healthcare, growing demand for stem cell preservation and awareness about its use with regards to treatment of diseases are expected to drive the growth of the market. Moreover, increasing awareness about personalized medicines and its applications are contributing to the growth of the market. According to the US Food and Drug Administration (FDA), The department has approved 16 personalized medicines in the year 2017, which accounts for 20% of total drug approvals.


The rising high price of biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.


Segmentation


The global biopreservation market has been segmented on the basis of product, biospecimen, and application.


On the basis of product, the market has been classified as media and equipment. The media subsegment has been further divided into nutrient media, sera, and growth factors and supplements. The equipment segment has been further divided into temperature control systems, accessories, alarms & monitoring systems, incubators, centrifuges, and other equipment. The temperature control systems segment has been further classified as freezers, cryogenic storage systems, thawing equipment, and refrigerators. The biospecimen segment has been divided into human tissue samples, organs, stem cells, and other biospecimens.


The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biopreservation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European biopreservation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The biopreservation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biopreservation market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Biopreservation Market Share, by Region, 2017 (%)


Biopreservation Market Share


Source: MRFR Analysis


The Americas are likely to dominate the global biopreservation market owing to the adoption of advanced technology, increasing spending on healthcare R&D, the presence of a well-established healthcare system, and increasing in-house sample storage in hospitals and research institutes. Moreover, presence and recent merger and acquisition activities by market players in the region are contributing to the growth of the market.  For instance, in 2017, Cesca Therapeutics Inc. has acquired Sacramento’s SynGen Inc. for USD 1 million with this acquisition company has managed to add cell separation and cord blood processing products in their portfolio.


The European market is expected to be the second-largest biopreservation market. The market growth in this region can be attributed to the increasing number of births and with-it continuous increase in demand for umbilical cord preservation. According to the European Commission, in the year 2016 more than 5.1 million babies were born in Europe.  Moreover, a growing number of sperm and egg banks is contributing to the growth of the market in this region.


Asia-Pacific is expected to be the fastest-growing biopreservation market during the forecast period owing to the increasing population in the region, increasing awareness about stem cell preservation and continuous development in the healthcare sector due to government funding.


The market in the Middle East & Africa is expected to account for the smallest share of the global biopreservation market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global biopreservation market are Thermo Fisher Scientific, Inc, VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., BioCision., Sigma-Aldrich Co., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Princeton CryoTech, Biomatrica, Inc., Panasonic Biomedical,  Inc., Chart Industries, and ATLANTA BIOLOGICALS


Global Biopreservation Market, by Product



  • Media


    • Nutrient Media

    • Sera

    • Growth Factors and Supplements


  • Equipment


    • Temperature Control Systems


      • Freezers

      • Cryogenic Storage Systems

      • Thawing Equipment

      • Refrigerators


    • Accessories

    • Alarms & Monitoring Systems

    • Incubators

    • Centrifuges

    • Other Equipment



Global Biopreservation Market, by Biospecimen



  • Human Tissue Samples

  • Organs

  • Stem Cells

  • Other Biospecimens


Global Biopreservation Market, by Application



  • Regenerative Medicine


    • Cell Therapy

    • Gene Therapy

    • Others


  • Biobanking


    • Human Eggs

    • Human Sperm

    • Veterinary IVF


  • Drug Discovery


Global Biopreservation Market, by Region



  • Americas

  • North America

  • US

  • Canada

  • South America

  • Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Middle East

  • Africa


Intended Audience



  • Biopreservation product manufacturers

  • Biopreservation product distributors and suppliers

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Contract research organizations (CROs)

  • Government associations

  • Market research and consulting



Frequently Asked Questions (FAQ) :


North America is expected to lead the Biopreservation Market.

The Biopreservation Market is projected to grow at an 11.2% CAGR between 2018-2023.

Rising expenditure on healthcare and awareness about personalized medicines are adding market growth.

High instrument price may limit market growth.

It is widely used in regenerative medicine, biobanking, and drug discovery.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Biopreservation Market, by Product

6.1 Introduction

6.2 Media

6.2.1 Nutrient Media

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 Sera

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3 Growth Factors and Supplements

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Equipment

6.3.1 Temperature Control Systems

6.3.1.1 Freezers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1.2 Cryogenic Storage Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1.3 Thawing Equipment

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1.4 Refrigerators

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2 Accessories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3 Alarms & Monitoring Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.4 Incubators

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.5 Centrifuges

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.6 Other Equipment

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Biopreservation Market, by Biospecimen

7.1 Introduction

7.2 Human Tissue Samples

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Organs

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Stem Cells

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Other Biospecimens

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Biopreservation Market, by Application

8.1 Introduction

8.2 Regenerative Medicine

8.2.1 Cell Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.2 Gene Therapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.3 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Biobanking

8.3.1 Human Eggs

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.2 Human Sperm

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.3 Veterinary IVF

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Drug Discovery

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Biopreservation Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Thermo Fisher Scientific, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 VWR International, LLC.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 CUSTOM BIOGENIC SYSTEMS.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 BioLife Solutions, Inc

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 BioCision

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Sigma-Aldrich Co

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 QIAGEN

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Lifeline Scientific

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Cesca Therapeutics

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Core Dynamics, Ltd.

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Princeton CryoTech

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Biomatrica, Inc.

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Panasonic Biomedical, Inc.,

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Chart Industries

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Atlanta Biologicals

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Biopreservation Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Biopreservation Market Synopsis, 2020-2027

Table 2 Global Biopreservation Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Biopreservation Market, by Region, 2020-2027 (USD Million)

Table 4 Global Biopreservation Market, by Product, 2020-2027 (USD Million)

Table 5 Global Biopreservation Market, by Biospecimen, 2020-2027 (USD Million)

Table 6 Global Biopreservation Market, by Application, 2020-2027 (USD Million)

Table 7 North America: Biopreservation Market, by Product, 2020-2027 (USD

Million)

Table 8 North America: Biopreservation Market, by Biospecimen, 2020-2027 (USD

Million)

Table 9 North America: Biopreservation Market, by Application, 2020-2027 (USD

Million)

Table 10 US: Biopreservation Market, by Product, 2020-2027 (USD Million)

Table 11 US: Biopreservation Market, by Biospecimen, 2020-2027 (USD Million)

Table 12 US: Biopreservation Market, by Application, 2020-2027 (USD Million)

Table 13 Canada: Biopreservation Market, by Product, 2020-2027 (USD Million)

Table 14 Canada: Biopreservation Market, by Biospecimen, 2020-2027 (USD Million)

Table 15 Canada: Biopreservation Market, by Application, 2020-2027 (USD

Million)

Table 16 South America: Biopreservation Market, by Product, 2020-2027 (USD

Million)

Table 17 South America: Biopreservation Market, by Biospecimen, 2020-2027 (USD

Million)

Table 18 South America: Biopreservation Market, by Application, 2020-2027 (USD

Million)

Table 19 Europe: Biopreservation Market, by Product, 2020-2027 (USD Million)

Table 20 Europe: Biopreservation Market, by Biospecimen, 2020-2027 (USD Million)

Table 21 Europe: Biopreservation Market, by Application, 2020-2027 (USD Million)

Table 22 Western Europe: Biopreservation Market, by Product, 2020-2027 (USD

Million)

Table 23 Western Europe: Biopreservation Market, by Biospecimen, 2020-2027 (USD

Million)

Table 24 Western Europe: Biopreservation Market, by Application, 2020-2027

(USD Million)

Table 25 Eastern Europe: Biopreservation Market, by Product, 2020-2027 (USD

Million)

Table 26 Eastern Europe: Biopreservation Market, by Biospecimen, 2020-2027 (USD

Million)

Table 27 Eastern Europe: Biopreservation Market, by Application, 2020-2027

(USD Million)

Table 28 Asia-Pacific: Biopreservation Market, by Product, 2020-2027 (USD

Million)

Table 29 Asia-Pacific: Biopreservation Market, by Biospecimen , 2020-2027 (USD

Million)

Table 30 Asia-Pacific: Biopreservation Market, by Application, 2020-2027 (USD

Million)

Table 31 Middle East & Africa: Biopreservation Market, by Product, 2020-2027

(USD Million)

Table 32 Middle East & Africa: Biopreservation Market, by Biospecimen, 2020-2027

(USD Million)

Table 33 Middle East & Africa: Biopreservation Market, by Application, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Biopreservation Market

Figure 3 Segmentation Market Dynamics for Global Biopreservation Market

Figure 4 Global Biopreservation Market Share, by Product, 2020

Figure 5 Global Biopreservation Market Share, by Biospecimen , 2020

Figure 6 Global Biopreservation Market Share, by Application, 2020

Figure 7 Global Biopreservation Market Share, by Region, 2020

Figure 8 North America: Biopreservation Market Share, by Country, 2020

Figure 9 Europe: Biopreservation Market Share, by Country, 2020

Figure 10 Asia-Pacific: Biopreservation Market Share, by Country, 2020

Figure 11 Middle East & Africa: Biopreservation Market Share, by Country, 2020

Figure 12 Global Biopreservation Market: Company Share Analysis, 2020 (%)

Figure 13 Thermo Fisher Scientific, Inc.: Key Financials

Figure 14 Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 15 Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 16 VWR International, LLC.: Key Financials

Figure 17 VWR International, LLC.: Segmental Revenue

Figure 18 VWR International, LLC.: Geographical Revenue

Figure 19 CUSTOM BIOGENIC SYSTEMS. : Key Financials

Figure 20 CUSTOM BIOGENIC SYSTEMS. : Segmental Revenue

Figure 21 CUSTOM BIOGENIC SYSTEMS. : Geographical Revenue

Figure 22 BioLife Solutions, Inc: Key Financials

Figure 23 BioLife Solutions, Inc: Segmental Revenue

Figure 24 BioLife Solutions, Inc: Geographical Revenue

Figure 25 BioCision: Key Financials

Figure 26 BioCision: Segmental Revenue

Figure 27 BioCision. Geographical Revenue

Figure 28 Sigma-Aldrich Co: Key Financials

Figure 29 Sigma-Aldrich Co: Segmental Revenue

Figure 30 Sigma-Aldrich Co: Geographical Revenue

Figure 31 QIAGEN: Key Financials

Figure 32 QIAGEN: Segmental Revenue

Figure 33 QIAGEN: Geographical Revenue

Figure 34 Lifeline Scientific: Key Financials

Figure 35 Lifeline Scientific: Segmental Revenue

Figure 36 Lifeline Scientific: Geographical Revenue

Figure 37 Cesca Therapeutics: Key Financials

Figure 38 Cesca Therapeutics: Segmental Revenue

Figure 39 Cesca Therapeutics: Geographical Revenue

Figure 40 Core Dynamics, Ltd.: Key Financials

Figure 41 Core Dynamics, Ltd.: Segmental Revenue

Figure 42 Core Dynamics, Ltd.: Geographical Revenue

Figure 43 Princeton CryoTech : Key Financials

Figure 44 Princeton CryoTech : Segmental Revenue

Figure 45 Princeton CryoTech : Geographical Revenue

Figure 46 Biomatrica, Inc.: Key Financials

Figure 47 Biomatrica, Inc.: Segmental Revenue

Figure 48 Biomatrica, Inc.: Geographical Revenue

Figure 49 Panasonic Biomedical, Inc.: Key Financials

Figure 50 Panasonic Biomedical, Inc.: Segmental Revenue

Figure 51 Panasonic Biomedical, Inc.: Geographical Revenue

Figure 52 Chart Industries: Key Financials

Figure 53 Chart Industries: Segmental Revenue

Figure 54 Chart Industries: Geographical Revenue

Figure 55 Atlanta Biologicals: Key Financials

Figure 56 Atlanta Biologicals: Segmental Revenue

Figure 57 Atlanta Biologicals: Geographical Revenue